ObsEva IPO: Early Stage Keeps Us Cautious On An IPO Investment
24 Jan 2017 13:40 GMT
… $87 million in its upcoming IPO. Based in Geneva, Switzerland, … . He previously co-founded PregLem, a Swiss specialty biopharmaceutical … experience comes from positions at PregLem, Serono, and Pierre Pabre … and analysis on the major IPOs each week, along with …
ObsEva Initiates IPO Filing For Women's Reproductive Treatments
10 Jan 2017 21:47 GMT
… statement for an undisclosed IPO amount. The company is … by former senior executives of PregLem SA, a specialty biopharma … 39;support' the IPO. The IPO underwriters include Credit Suisse, … closer to the IPO. I write about technology IPOs, follow-ons, …
Alentis Therapeutics Announces Appointments of Luca Santarelli to the Board of Directors and Rafaèle Tordjman as Chairperson
09 Nov 2021 06:00 GMT
… .6 million in a NASDAQ IPO in April this year. Prior … Therapeutics [FLXN], Obseva [OBSV] and Preglem, before the company was sold …
Inotrem Bolsters Leadership Team With the Appointment of Sven Zimmermann as New CEO
24 Mar 2021 09:34 GMT
… ’s IPO on Nasdaq as well as the acquisition of PregLem by …